Clinical validation of hrHPV testing on vaginal and urine self-samples in primary cervical screening (cross-sectional results from the Papillomavirus Dumfries and Galloway-PaVDaG study).

Last updated on 22-8-2019 by Anonymous (niet gecontroleerd)

Peer reviewed scientific article



OBJECTIVES: Papillomavirus Dumfries and Galloway (PaVDaG) assessed the performance of a high-risk human papillomavirus (hrHPV) PCR-based assay to detect high-grade cervical intraepithelial neoplasia (CIN2+) in self-collected vaginal and urine samples.SETTING: Women attending routine cervical screening in primary care.PARTICIPANTS: 5318 women aged 20-60 years provided self-collected random urine and vaginal samples for hrHPV testing and a clinician-collected liquid-based cytology (LBC) sample for cytology and hrHPV testing.INTERVENTIONS: HrHPV testing. All samples were tested for hrHPV using…

Associated health topics:

QR code

QR code for this page URL